Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 8/20 | 0.42 |
| ▸ | AR | P10275 | 8/20 | 0.42 |
| ▸ | SHBG | P04278 | 3/20 | 0.36 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.36 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.35 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24444457 | 1.00 | NR3C1 (0.42) | NR3C1ARSHBGSERPINA6SLC22A1 | |
| SCHEMBL5897753 | 0.83 | NR3C1 (0.38) | NR3C1ARSHBGSERPINA6SLC22A1 | |
| SCHEMBL22918272 | 0.82 | CYP3A4 (0.37) | ARCYP19A1CYP3A4 | |
| SCHEMBL24444338 | 0.82 | CYP3A4 (0.37) | ARCYP19A1CYP3A4 | |
| SCHEMBL9005205 | 0.82 | SRD5A2 (0.34) | NR3C1ARALDH1A1PGRCYP3A4 | |
| SCHEMBL24444511 | 0.82 | CYP3A4 (0.37) | ARCYP19A1CYP3A4 | |
| SCHEMBL3198102 | 0.81 | NR3C1 (0.33) | NR3C1ARPGR | |
| SCHEMBL27062879 | 0.79 | AR (0.38) | NR3C1ARSHBGSERPINA6SLC22A1 | |
| SCHEMBL5925783 | 0.79 | CYP19A1 (0.43) | CYP19A1 | |
| SCHEMBL24461176 | 0.78 | AR (0.37) | NR3C1ARSHBGSERPINA6SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025941-A1 | IMPROVED PROCESS FOR THE PREPARATION OF TRENBOLONE AND/OR TRENBOLONE ACETATE | F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2024-01-25 | — | — | US | disclosed |
| US-20240025941-A1 | IMPROVED PROCESS FOR THE PREPARATION OF TRENBOLONE AND/OR TRENBOLONE ACETATE | F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2024-01-25 | — | — | US | disclosed |
| WO-2022106566-A1 | PROCESS FOR THE PREPARATION OF TRENBOLONE ACETATE HAVING A DEFINITE PARTICLE SIZE DISTRIBUTION AND A IRREGULAR HEXAGON PLATES CRYSTAL HABIT | F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022106574-A1 | IMPROVED PROCESS FOR THE PREPARATION OF TRENBOLONE AND/OR TRENBOLONE ACETATE | F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT) | 2022-05-27 | — | — | WO | disclosed |
| EP-4001288-A1 | PROCESS FOR THE PREPARATION OF TRENBOLONE ACETATE HAVING A DEFINITE PARTICLE SIZE DISTRIBUTION AND A IRREGULAR HEXAGON PLATES CRYSTAL HABIT | F.I.S.- Fabbrica Italiana Sintetici S.p.A. (IT) | 2022-05-25 | — | — | EP | disclosed |
| EP-4000688-A1 | PROCESS FOR THE PREPARATION OF TRENBOLONE ACETATE HAVING A DEFINITE PARTICLE SIZE DISTRIBUTION | F.I.S.- Fabbrica Italiana Sintetici S.p.A. (IT) | 2022-05-25 | — | — | EP | disclosed |
| EP-4001289-A1 | IMPROVED PROCESS FOR THE PREPARATION OF TRENBOLONE AND/OR TRENBOLONE ACETATE | F.I.S.- Fabbrica Italiana Sintetici S.p.A. (IT) | 2022-05-25 | — | — | EP | disclosed |
| WO-2021012673-A1 | METHOD FOR PREPARING TRENBOLONE ACETATE | 浙江神洲药业有限公司 | 2021-01-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025941-A1 | IMPROVED PROCESS FOR THE PREPARATION OF TRENBOLONE AND/OR TRENBOLONE ACETATE | CYP11B1, CYP17A1, CYP11B2 | NR3C1 117/4885AR 132/4885SHBG 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.